449 related articles for article (PubMed ID: 14605674)
1. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
[TBL] [Abstract][Full Text] [Related]
2. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria.
Yamaguchi H; Bhalla K; Wang HG
Cancer Res; 2003 Apr; 63(7):1483-9. PubMed ID: 12670894
[TBL] [Abstract][Full Text] [Related]
3. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity.
van Loo G; van Gurp M; Depuydt B; Srinivasula SM; Rodriguez I; Alnemri ES; Gevaert K; Vandekerckhove J; Declercq W; Vandenabeele P
Cell Death Differ; 2002 Jan; 9(1):20-6. PubMed ID: 11803371
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
[TBL] [Abstract][Full Text] [Related]
5. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
[TBL] [Abstract][Full Text] [Related]
6. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
7. Toxic proteins released from mitochondria in cell death.
Saelens X; Festjens N; Vande Walle L; van Gurp M; van Loo G; Vandenabeele P
Oncogene; 2004 Apr; 23(16):2861-74. PubMed ID: 15077149
[TBL] [Abstract][Full Text] [Related]
8. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.
Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL
Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
[TBL] [Abstract][Full Text] [Related]
10. Activation of HtrA2, a mitochondrial serine protease mediates apoptosis: current knowledge on HtrA2 mediated myocardial ischemia/reperfusion injury.
Bhuiyan MS; Fukunaga K
Cardiovasc Ther; 2008; 26(3):224-32. PubMed ID: 18786092
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
12. Omi/HtrA2 and XIAP are components of platelet apoptosis signalling.
Winkler J; Rand ML; Schmugge M; Speer O
Thromb Haemost; 2013 Mar; 109(3):532-9. PubMed ID: 23306356
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.
Vande Walle L; Wirawan E; Lamkanfi M; Festjens N; Verspurten J; Saelens X; Vanden Berghe T; Vandenabeele P
Cell Res; 2010 Apr; 20(4):421-33. PubMed ID: 20125124
[TBL] [Abstract][Full Text] [Related]
14. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells.
Sekine K; Hao Y; Suzuki Y; Takahashi R; Tsuruo T; Naito M
Biochem Biophys Res Commun; 2005 Apr; 330(1):279-85. PubMed ID: 15781261
[TBL] [Abstract][Full Text] [Related]
15. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
16. Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2.
Hong SK; Cha MK; Kim IH
Free Radic Biol Med; 2006 Jan; 40(2):275-84. PubMed ID: 16413409
[TBL] [Abstract][Full Text] [Related]
17. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
18. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions.
Egger L; Schneider J; Rhême C; Tapernoux M; Häcki J; Borner C
Cell Death Differ; 2003 Oct; 10(10):1188-203. PubMed ID: 14502242
[TBL] [Abstract][Full Text] [Related]
19. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.
Yang QH; Church-Hajduk R; Ren J; Newton ML; Du C
Genes Dev; 2003 Jun; 17(12):1487-96. PubMed ID: 12815069
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis.
Estaquier J; Arnoult D
Cell Death Differ; 2007 Jun; 14(6):1086-94. PubMed ID: 17332775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
